Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05963204 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05963204: Completed NA study, sponsored by Galderma R&D.
NCT05963204 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05963204, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography
Primary Outcome
Percent change in collagen fiber density using Line-Field Confocal Optical Coherence Tomography at defined timepoints compared to baseline. Collagen density is defined as a number of fibers and is measured on each side of the midface.
Interventions
- COMBINATION_PRODUCT Sculptra and Alastin Restorative Skin Complex
- COMBINATION_PRODUCT Sculptra and CeraVe Daily Moisturizing Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-07-07 |
| Est. Completion | 2024-03-19 |
| Phase | NA |
What the finished NCT05963204 record still lists
NCT05963204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sculptra and Alastin Restorative Skin Complex is the first listed.
NCT05963204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05963204 about?
NCT05963204 is a clinical study titled "A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen". To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography
What is the current status of trial NCT05963204?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-07-07. Estimated completion is 2024-03-19.
What interventions are being tested in trial NCT05963204?
The interventions under investigation include: Sculptra and Alastin Restorative Skin Complex (COMBINATION_PRODUCT), Sculptra and CeraVe Daily Moisturizing Lotion (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05963204?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05963204's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI